Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the target of some unusual options trading activity on Wednesday. Investors acquired 1,885 put options on the stock. This represents an increase of 1,101% compared to the average daily volume of 157 put options.
Evelo Biosciences Trading Down 50.0%
Evelo Biosciences stock opened at $0.00 on Friday. Evelo Biosciences has a 12-month low of $0.00 and a 12-month high of $0.00. The firm has a market cap of $1,884.00, a P/E ratio of 0.00 and a beta of 0.38.
About Evelo Biosciences
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.
The company’s pipeline spans inflammatory, autoimmune and oncology indications.
Further Reading
- Five stocks we like better than Evelo Biosciences
- Free: The Crypto Summit That Could Change Your Life
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
